The bioanalysis of cell and gene therapies requires more than what traditional chromatographic or ligand-binding methods can offer. These highly complex therapies require bioanalytical scientists with expertise in molecular biology and immunogenicity methodologies, both ligand binding and cell-based assays, flow cytometry and ELISpot in a regulated (GxP) environment.

Somru Scientists have deep scientific expertise and regulatory knowledge to develop robust and novel bioanalytical methods (e.g., molecular , assays, immunoassay and cell-based assays) to support biodistribution, safety, efficacy, and immunogenicity of innovative cell and gene therapeutic candidates.